Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Seattle Genetics Incorporated

Highlights

A collection of news and information related to Seattle Genetics Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-4 of 4
» View baltimoresun.com items only
    May 8, 2013 |Story| Reuters
  1. U.S. RESEARCH ROUNDUP: Walt Disney, Electronic Arts, Metlife, Comerica

    Reuters
    May 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Walt Disney and Electronic Arts, on Wednesday. HIGHLIGHTS * Comerica Inc : Baird cuts to underperform * Electronic Arts :...

    Tags: Discovery Communications, Inc., Home Properties Incorporated, Essex Property Trust Inc., Rockwood Holdings Incorporated, Engineering

  2. Apr 22, 2013 |Story| Reuters
  3. U.S. RESEARCH ROUNDUP: Apple, IBM, GE, Kimberly-Clark, Caterpillar

    Reuters
    April 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Apple, IBM and GE, on Monday. HIGHLIGHTS * Apple : BMO, Sterne Agee cut target price on the stock * IBM : Goldman Sachs,...

    Tags: FedEx Corporation, Alkermes Incorporated, Broadcom Corp., TCF Financial Corporation, Metal and Mineral

  4. Aug 22, 2011 |Story| Reuters
  5. Seattle Genetics cancer drug price may top $100,000

    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
    Reuters
    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...

    Tags: Senior Health, Prostate Cancer, Drugs and Medicines, Cancer, Bristol Myers Squibb Company

  6. Jul 12, 2011 |Story| KCPQ-LTV
  7. FDA eyes trial size for Seattle Genetics cancer drug

    Reuters
    Seattle Genetics' experimental cancer drug showed promise in treating two rare types of blood cancer, but the design and size of clinical trials limited conclusions, U.S. drug reviewers said. Food and Drug Administration staff also said the trials for...

    Tags: Europe, JPMorgan Chase & Co., Drugs and Medicines, Science, Medical Specialization

Original site for Seattle Genetics Incorporated topic gallery.